Infectious Answers

World Health Organisation expert plays down fears of pandemic, saying prolonged contact is needed to transmit disease

Research news from leading universities

Researchers at the Rockefeller University and a pharmaceutical company have developed a new antibiotic that kills a wide range of bacteria.

Superbugs result in billions in health care costs.

Superbugs are a new scary reality. The bugs are resistant to antibiotics, they multiply by the billions, and they thrive in environments that would kill off most other living organisms.

Researchers at Papworth Hospital, the University of Cambridge, and the Wellcome Trust Sanger Institute reported the first DNA confirmation of person to person t

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes re

Researchers from Tufts University School of Medicine have identified an isolate of E. coli resistant to a class of drugs called carbapenems.

Scientists have developed a medical dressing that 'lights up' when a burn is infected.

Our best defence against a new coronavirus found in the Middle East rests on the quietly heroic work of health officials during the 2003 Sars outbreak, writes Kevin Fong

Researchers have found a bacterial infection that could help control malaria by making mosquitoes resistant to the parasite.

New research is a significant development in combating antibiotic resistance; it will pave the way for the creation of the inhibitors to counteract the process, allowing a renaissance in the use of antibiotics.

It's often very easy to get a prescription for penicillin or azithromycin—even when we often don't even need the medication.

Biomimetic nanosponge potentially offers a detoxification treatment for a variety of injuries and diseases caused by pore-forming toxins, such as alpha-haemolysin toxin from MRSA.

British scientists develop a new way to create an entirely synthetic vaccine which does not rely on using live infectious virus, meaning it is much safer.

Health officials say they are disappointed in the uptake of the vaccines at the centre of a measles epidemic said to be spreading at an "alarming rate".

Bacteria could soon be acting as microscopic "bio-batteries" thanks to a joint UK-US research effort.

Gina Pugliese, RN, MS, vice president of the Premier healthcare alliance's Safety Institute, explains why hand hygiene should be a patient safety priority, and how healthcare organizations can succeed in improving hand hygiene compliance.